RFU v Stephen Hihetah

To optimise for archiving, the original image and related documents associated with this article have been removed.

A decision in the case of the Rugby Football Union (RFU) v Stephen Hihetah has been published by the National Anti-Doping Panel (NADP).

On 21 February 2019 Stephen Hihetah, a player registered with Hull RFC and the RFU, provided a urine sample.  The urine sample returned Adverse Analytical Findings for two stanozolol metabolites, a metandienone metabolite and a tamoxifen metabolite. Mr Hihetah was subsequently charged on 12 June 2019 with an Anti-Doping Rule Violation (ADRV) for breaching World Rugby Regulation 21.2.1 for the Presence of Prohibited Substances or their Metabolites or Markers.

Mr Hihetah admitted the ADRV but contested that the Presence of these substances in his system had not been intentional.  Having considered the evidence before them the NADP Tribunal, consisting of Jeremy Summers and Dr Mike Irani, determined that Mr Hihetah had failed to establish that he had not acted intentionally on the balance of probabilities.  The Tribunal imposed a period of ineligibility of 4 years, running from 12 June 2019 until midnight on 11 June 2023.

A copy of the full decision can be accessed via the related links tab on the right-hand side.

The National Anti-Doping Panel (NADP) is the United Kingdom’s independent tribunal responsible for adjudicating anti-doping disputes in sport. It is operated by Sport Resolutions and is entirely independent of UK Anti-Doping who is responsible for investigating, charging and prosecuting cases before the NADP.

You may also like

View All

Enhanced Games sues World Aquatics, WADA and USA Swimming for $800m

The privately funded 2026 Enhanced Games set to take place in Las Vegas allows athletes to use performance enhancing substances without being subject to drug tests. It is now suing World Aquatics, the World Anti-Doping Agency and USA Swimming for $800m after accusing them of orchestrating an unlawful effort to discourage athletes from participating

Read More

Serena Williams latest sportsperson to promote GLP-1 weight loss medication, fuelling criticism

23-time Grand Slam tennis champion Serena Williams is the latest sportsperson to promote weight loss medication like Ozempic, fuelling criticism over possibly encouraging toxic beauty standards, discouraging healthy habits, and the fact that she has affiliated herself with drugs that the World Anti-Doping Agency added to its monitored substances list

Read More

UKAD employs an all-female team of Doping Control Personnel for the Women’s Rugby World Cup 2025

UKAD has employed an all-female team of Doping Control Personnel for World Rugby to assist with the Women’s Rugby World Cup 2025. The tournament also features the largest cohort of female coaches in the event’s history

Read More